article thumbnail

Royal DSM reveals audited results of its progress in addressing societal and environmental challenges

Express Pharma

Working with partners including the World Food Program, UNICEF and Sight and Life, DSM will extend its impact as it targets helping to close the micronutrient gap of 800 million people by 2030. The company aims to support 500 million people by 2030. per cent); phosphorus eutrophication from poultry farming (by 6.8 per cent).

article thumbnail

mRNA licensing agreements rise 800% in value as confidence grows beyond vaccines

Express Pharma

Ophelia Chan, Business Fundamentals Senior Analyst at GlobalData, comments, “The COVID-19 pandemic highlighted the key advantages of mRNA technology in vaccine development, including rapid production, precise immune targeting, and streamlined manufacturing- factors that drove the success of mRNA-based COVID-19 vaccines.” billion in 2030.

Vaccines 104
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

article thumbnail

First COVID-19 impact report on global vaccine markets

European Pharmaceutical Review

Achieving Immunization Agenda 2030 goals. The report highlighted opportunities for more alignment of vaccine development, production and distribution with a public health agenda, towards achieving the Immunization Agenda 2030 (IA2030) goals and informing pandemic prevention, preparedness and response efforts.

article thumbnail

WHO prequalifies meningitis conjugate vaccine

European Pharmaceutical Review

They do not promote herd immunity and are not generally effective in infants and children younger than two years old. Therefore, having access to this vaccine will “move us closer to defeating meningitis by 2030″ noted the UK’s International Development Minister Andrew Mitchell. However, they only provide short-term protection.

article thumbnail

Vaccines Europe launches first pipeline review

European Pharmaceutical Review

Vaccines Europe states that the actions must be addressed to ensure the European Beating Cancer Plan and the Immunization Agenda 2030 are met. The organisation claims it is crucial to account for vaccine specificities when shaping Europe’s research ecosystem, through revision of the General Pharmaceutical Legislation.

article thumbnail

Sun Pharma agrees deal to buy alopecia player Concert

pharmaphorum

Alopecia areata is an autoimmune disease in which the immune system attacks the body’s hair follicles, causing hair to fall out, predominantly on the scalp, but also sometimes affecting other areas of the body like eyebrows, eyelashes, and facial hair. .” The $11.50

article thumbnail

Country focus: China & APAC’s growing medical needs bring opportunities and challenges

pharmaphorum

The entire APAC region already accounts for 30% of all global pharma spending, and within these markets national healthcare expenditure is expected to increase threefold to over $2 trillion by 2030. million in 2030. New cancer cases in China increased from 4 million in 2015 to 4.4 million in 2019, and are estimated to increase to 5.7